Riboksin, wa'azi ga alamomi, sashi, illa da kuma contraindications pobochnymu

"Riboxinum" da aka samar a cikin nau'i na alluna ko a cikin bayani ga igiyar jini gwamnati. The aiki abu shiri ne inosine, nasa ne da kungiyar daga waɗanda pharmaceutical jamiái cewa normalize tsokar metabolism, rage nama hypoxia.

"Riboxinum" wa'azi nuna gusar arrhythmia kara habaka tafiyar matakai na rayuwa a cikin myocardium, inganta wurare dabam dabam na oxygen a cikin jiki. Inosine shirya makamashi balance hari, ya mayar jijiyoyin zuciya wurare dabam dabam, ya hana rikitarwa bayan intraoperative koda ischemia. "Riboksin" da hannu a cikin assimilation na glucose iya shafar metabolism a lokacin hypoxia, ko da a cikin yanayi na rashi na adenosine triphosphate.

"Riboxinum", da wa'azi ƙayyade mataki activates pyruvic acid, game da shi, samar da wani nama numfasawa. stimulating sakamako a kan kira na nucleotides. Da miyagun ƙwayoyi qara aiki na wasu enzymes kunshe a cikin Krebs sake zagayowar. Inosine ratsa cikin Kwayoyin, qara tsanani da contractions daga cikin zuciya tsoka, da myocardium hūta lokacin da diastolic aiki, a sakamakon qara jini girma bauta.

Da miyagun ƙwayoyi rage samuwar platelets qara regenerative iya aiki na nama, kamar mucous membranes na ciki da kuma hanjinsu, myocardium.

"Riboksin" alamomi ga yin amfani da

Da miyagun ƙwayoyi ne aka yi nufi ga Hadakar magani daga manya da jijiyoyin zuciya da cututtukan zuciya, fi bayan tsokar zuciya infarction da cardiac arrhythmia, wanda ake sa ta yin amfani da cardiac glycosides.

Inosine gudanar a da yawa hanta cututtuka: hepatitis, cirrhosis, m hanta degeneration (a sakamakon barasa zagi, kwayoyi). idan urokoproporfirii.

"Riboksin" wa'azi ga dosing

Da miyagun ƙwayoyi a Allunan bada shawarar ga manya to sami abinci.

A kullum kashi da aka zaba daga 0.6 g to 2.4 g kullum kashi da aka hankali ya karu daga kashi 0.6 g a portability zuwa na biyu ko na uku ranar da shawarar zuwa 1.2 g, da kuma, idan ya cancanta, gyarawa da halartar likita, - har zuwa 2.4 g, rarraba shi a cikin uku, saukarwa.

Duration daga cikin shakka dogara a kan yanayin shaida, jere daga 4 makonni zuwa 1.5 ko har watanni 3.

Lokacin da urokoproporfirii wajabta kullum kashi 0.8 g, samun 200 MG Inosine 4 sau. Medicine "Riboksin" dauki wani lokaci na 1 zuwa 3 watanni -x.

Lokacin da igiyar jini drip ko digon fara kashi na 200 MG aka zaba daya-lokaci, sa'an nan ya karu zuwa 400 MG, rabu da 1-2 dropper kowace rana. A hanya na lura, likita ya kafa akayi daban-daban, dangane da haƙuri da yanayin.

"Riboksin" jagora zuwa gefen effects

A rare lokuta, rashin lafiyan halayen da za su iya faruwa urticaria, pruritus, flushing daga cikin fata. Illar bace bayan miyagun ƙwayoyi janye.

A rare lokuta, saboda da liyafar na inosine aka ƙara adadin uric acid a cikin jini rafi. A sakamakon haka, marasa lafiya samun dogon koka na worsening gout.

"Riboksin" wa'azi ga contraindications

Ba za ka iya rubũta kwayoyi inosine mutane da hypersensitivity to daya daga cikin aka gyara na da magani ga gout da hyperuricemia.

Akwai contraindications da yin amfani da "riboksin" marasa lafiya fama da rashin ha} uri fructose, wani ciwo na malabsorption na glucose da kuma / ko galactose-gurgunta, a cikin jiki sucrase da / ko isomaltase.

Inosine lura da marasa lafiya da na koda gazawar ko ciwon sukari ne da za'ayi kawai a karkashin kulawa na likita, da nada kwayoyi na bukatar taka tsantsan.

A tasiri daga cikin miyagun ƙwayoyi a kan tayin a mata masu juna biyu ba a saita, don haka magani "riboksin" a lokacin daukar ciki ne contraindicated. Safety na aikace-aikace na inosine mata breastfed jariran madara ya ba da aka kafa. Saboda haka, da nada "riboksin" shayar da mama, shi ne shawarar ba to shãyar da mãma.